Automating data extraction from clinical documents offers significant potential to improve efficiency in healthcare settings, yet deploying Natural Language Processing (NLP) solutions presents practical challenges. Drawing upon our experience implementing various NLP models for information extraction and classification tasks at the British Columbia Cancer Registry (BCCR), this paper shares key lessons learned throughout the project lifecycle. We emphasize the critical importance of defining problems based on clear business objectives rather than solely technical accuracy, adopting an iterative approach to development, and fostering deep interdisciplinary collaboration and co-design involving domain experts, end-users, and ML specialists from inception. Further insights highlight the need for pragmatic model selection (including hybrid approaches and simpler methods where appropriate), rigorous attention to data quality (representativeness, drift, annotation), robust error mitigation strategies involving human-in-the-loop validation and ongoing audits, and building organizational AI literacy. These practical considerations, generalizable beyond cancer registries, provide guidance for healthcare organizations seeking to successfully implement AI/NLP solutions to enhance data management processes and ultimately improve patient care and public health outcomes.

As an industry defined by the relationship between patient and carer, at first glance it may seem incongruous to nudge healthcare towards a robotic future. In fact, artificial intelligence (AI) has the potential to completely reshape the health industry, offering greater support to human capabilities and allowing healthcare organizations to deliver higher-quality services more efficiently. AI is a broad term for computer systems that can "think" and act like humans. They can sense their environment, absorb information, learn from past experience, make decisions and take action. AI has transformative power for two reasons: the explosive growth in data, coupled with huge computational advances and processing speeds.

Objectives: Most cancer data sources lack information on metastatic recurrence. Electronic medical records (EMRs) and population-based cancer registries contain complementary information on cancer treatment and outcomes, yet are rarely used synergistically. To enable detection of metastatic breast cancer (MBC), we applied a semi-supervised machine learning framework to linked EMR-California Cancer Registry (CCR) data. Materials and Methods: We studied 11,459 female patients treated at Stanford Health Care who received an incident breast cancer diagnosis from 2000-2014. The dataset consisted of structured data and unstructured free-text clinical notes from EMR, linked to CCR, a component of the Surveillance, Epidemiology and End Results (SEER) database. We extracted information on metastatic disease from patient notes to infer a class label and then trained a regularized logistic regression model for MBC classification. We evaluated model performance on a gold standard set of set of 146 patients. Results: There are 495 patients with de novo stage IV MBC, 1,374 patients initially diagnosed with Stage 0-III disease had recurrent MBC, and 9,590 had no evidence of metastatis. The median follow-up time is 96.3 months (mean 97.8, standard deviation 46.7). The best-performing model incorporated both EMR and CCR features. The area under the receiver-operating characteristic curve=0.925 [95% confidence interval: 0.880-0.969], sensitivity=0.861, specificity=0.878 and overall accuracy=0.870. Discussion and Conclusion: A framework for MBC case detection combining EMR and CCR data achieved good sensitivity, specificity and discrimination without requiring expert-labeled examples. This approach enables population-based research on how patients die from cancer and may identify novel predictors of cancer recurrence.